FDA Commissioner nominee Robert Califf, who promised the Senate he would push for tougher postmarket surveillance of devices and drugs, is expected to clear a Jan. 12 confirmation vote from the Senate Help, Education, Labor and Pensions Committee.
Two Senators who said they would place blocks on Califf’s appointment in December, Sens. Lisa Murkowski, R-Alaska and Ben Sasse, R-Neb., have removed their objections. Murkowski objected to FDA’s approval...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?